Evaluation of Group Health Teaching With Video in Diabetic Patients

Objective:Health videos and group education to allow patients to a correct understanding of diabetes and insulin treatment.

Method:

Standards and number of patients: The patients received subcutaneous insulin injection, estimated 30 people enrolled.

Experimental Design and Methods:

1. Screening out-patient treatment with insulin use, HbA1c> 8% or poor postprandial glucose (PPG) 2. At the time of the visits, invite the patient to participate in the Video group education on insulin therapy By answering some questions about insulin injections, such as: do not know how to perform; afraid of the pain; fear of inconvenience, give patients time to complete the questionnaire.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chang Gung Memorial Hospital

Taoyuan, Taiwan, 333

About this study

Diabetes is a long-term chronic disease. The patients need to correct "knowledge and action" lifestyle in order to achieve effective blood glucose control. Upon the general control of diabetic patients in Taiwan, however, glycosylated hemoglobin (HbA1c) is not satisfactory. One of the important reasons is the low rate of insulin injection. For the use of insulin, the patient has many misconception. The patients in the clinic need to spend a lot of time to explain and description, but the results are not necessarily good. So we hope that in this part of the health education activities through organized groups Videos to assist doctors and patients as a bridge of communication, to enhance diabetes doctor thus contributing to glycemic control results.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Willing to sign the informed consent
Age over 20 years old
HbA1c>8% or PPG) > 200 mg/dl even under insulin therapy

Exclusion criteria

Vegetation status
Inability of visual or hearing contact with the video program

Treatment and study plan

Video

Behavioral

Primary outcomes

HbA1c

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Registry information

Acronym: EGVD

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: Aug 6, 2013
Registry last updated: Jun 10, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed